Package Leaflet: Information for the Patient
Bilastina Teva 10 mg Oral Disintegrating TabletsEFG
Read the entire package leaflet carefully before starting to take this medication,as it contains important information for you.
Contents of the Package Leaflet
5 Conservation of Bilastina Teva
Bilastina Teva contains bilastina as the active substance, which is an antihistamine.
Bilastina is used to relieve the symptoms of allergic rhinoconjunctivitis (sneezing, nasal itching, nasal discharge, nasal congestion, and red and itchy eyes) and other forms of allergic rhinitis. It may also be used to treat skin eruptions with itching (hives or urticaria).
Bilastina Teva 10 mg oral disintegrating tablets are indicated for children from 6 years of age with a minimum body weight of 20 kg and are also indicated for adults and adolescents.
Do not take Bilastina Teva:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Bilastina Teva if you or your child have moderate or severe renal or hepatic impairment, low levels of potassium, magnesium, or calcium in the blood, if you have or have had heart rhythm problems or if your heart rate is very low, if you are taking medications that may affect heart rhythm, if you have or have had a certain abnormal pattern in heartbeats (known as QTc interval prolongation in the electrocardiogram) that may occur in some forms of heart disease, or if you or your child are taking other medications (see "Other medications and Bilastina Teva").
Children
Do not administer this medication to children under 6 years of age with a body weight below 20 kg, as there are insufficient data available.
Other medications and Bilastina Teva
Tell your doctor or pharmacist if you or your child are taking, have recently taken, or may take any other medication.
Some medications should not be taken together, and other medications may require a dose adjustment when taken together.
Always inform your doctor or pharmacist if you or your child are taking or receiving any of the following medications in addition to Bilastina Teva:
Taking Bilastina Teva with food, beverages, and alcohol
These tablets should notbe taken with food or withgrapefruit juice or other fruit juices, as this would decrease the effect of bilastina. To avoid this, you can:
Bilastina, at the recommended dose in adults (20 mg), does not increase somnolence produced by alcohol.
Pregnancy, breastfeeding, and fertility
There are no data or limited data available on the use of bilastina in pregnant women and during breastfeeding, and on the effects on fertility.
If you are pregnant or breastfeeding, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Consult your doctor or pharmacist before taking any medication.
Driving and using machines
It has been shown that bilastina 20 mg does not affect performance during driving in adults.
However, each patient's response to the medication may be different.
Therefore, check how this medication affects you or your child before driving, operating machinery, or riding a bicycle.
Bilastina Teva contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per oral disintegrating tablet; i.e., it is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Use in adults and adolescents 12 years and older
The recommended dose in adults, including elderly people and adolescents 12 years and older, is 20 mg (two 10 mg tablets) once a day.
Use in children
The recommended dose in children from 6 to 11 years of age with a minimum body weight of 20 kg is one 10 mg tablet once a day. Do not administer this medication to children under 6 years of age with a body weight below 20 kg, as there are insufficient data available.
Since the duration of treatment depends on the underlying disease, your doctor will determine how long you or your child should take Bilastina Teva.
If you take more Bilastina Teva than you should
If you or your child exceed the dose of this medication, inform your doctor immediately or go to the emergency department of the nearest hospital. Please remember to bring this medication packaging or this package leaflet with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Bilastina Teva
Do nottake a double dose to make up for forgotten doses.
If you forget to administer the daily dose to your child on time, administer it the same day as soon as you remember. Then, administer the next dose the following day at the usual time as indicated by your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
If you stop treatment with Bilastina Teva
In general, no effects will appear after stopping treatment with Bilastina Teva.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
If you or your child experience allergic reactions whose symptoms may include difficulty breathing, dizziness, collapse, or loss of consciousness, swelling of the face, lips, tongue, or throat, and/or swelling and redness of the skin, stop administering this medication and go to your doctor immediately.
Other side effects that may appearin children:
Frequent: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Side effects that may appearin adults and adolescents:
Frequent: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Frequency not known: cannot be estimated from available data
Reporting side effects
If your child experiences any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and on the blister after CAD/EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the Sigre Collection Point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Bilastina Teva
Each tablet contains 10 mg of bilastina.
Mannitol (E 421), microcrystalline cellulose, sodium croscarmellose (see section 2 "Bilastina Teva contains sodium"), aluminum and magnesium metasilicate, sucralose, strawberry flavor, magnesium stearate, and anhydrous colloidal silica.
Appearance of the product and contents of the packaging
Bilastina Teva 10 mg oral disintegrating tablets EFG are round, biconvex tablets, approximately 7.5 mm in size, white to off-white in color, smooth to speckled, engraved with "10" on one side and smooth on the other side.
The tablets are packaged in blisters of 10, 20, 30, or 50 tablets.
Only some pack sizes may be marketed.
Marketing authorization holder
Teva B.V.
Swensweg 5, 2031GA Haarlem
Netherlands
Manufacturer:
Saneca Pharmaceuticals a.s.
Nitrianska 100 920 27 Hlohovec
Slovak Republic
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11 Edificio Albatros B 1ª planta
28108 Alcobendas – Madrid (Spain)
Date of the last revision of thispackage leaflet:September 2022
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The average price of BILASTINA TEVA 10 mg ORALLY DISINTEGRATING TABLETS in October, 2025 is around 2.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.